MedAI Verdict
All comparisons

Kardia 12L vs MyoVista wavECG

A practice that wants a 12-lead tracing with AI interpretation in the exam room can buy Kardia 12L today. It lists at $2,295, which covers the device, the KardiaStation app, KardiaPro access and a three-year warranty. The listing does not say whether that price recurs.

MyoVista wavECG received its 510(k) on October 5, 2026 without an AI-ECG algorithm. HeartSciences says it does not intend to commercialize the device until an algorithm is cleared and gives no timeline, and its site says its AI-ECG products are not commercially available in the United States. By the vendor's description, MyoVista Insights is meant for sites that pool tracings from several 12-lead devices and want third-party AI-ECG models in one review workflow. For a practice that needs AI-read ECGs this quarter, HeartSciences loses.

Decision support · Reviewed November 2, 2026

Kardia 12L logo

Kardia 12L

by AliveCor

Portable 12-lead ECG device with FDA-cleared AI interpretation, sold to clinicians with KardiaPro patient management access.

MyoVista wavECG logo

MyoVista wavECG

by HeartSciences

12-lead resting ECG device for cardiology clinics, FDA 510(k) cleared in October 2026 without its AI-ECG algorithm.

When to pick each one

Kardia 12L

  • Listed at $2,295 with device and KardiaPro access, recurrence not stated
  • Three-year warranty included
Read the full Kardia 12L review

MyoVista wavECG

  • 510(k) for a 12-lead resting ECG, no AI algorithm
  • Vendor describes a device-agnostic ECG management platform
Read the full MyoVista wavECG review

Score

Each row shows points earned of points available under the published rubric.

Kardia 12L

38of 100

Competitive

MyoVista wavECG

31of 100

Competitive
Score by dimension for Kardia 12L and MyoVista wavECG
DimensionKardia 12LMyoVista wavECGDifference
FDA clearance12 / 1212 / 120
HIPAA / SOC2 / BAA10 / 106 / 10+4
EHR integrations (count)0 / 5.61.7 / 5.6-1.7
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.81.9 / 4.8-1.9
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers0 / 210 / 210
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal8.4 / 123 / 12+5.4
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Kardia 12L

TierMonthlyAnnualNotes
Kardia 12Ln/an/aIncludes the device, KardiaStation app, KardiaPro access and a 3-year warranty, with a 90-day return policy. Two-week trial for eligible U.S. HCPs by form. The page does not state whether the price is one-time or recurring.

MyoVista wavECG

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

Kardia 12L

FDA decisions

Show 14 more

MyoVista wavECG

FDA decisions

Compliance and integrations

Documented from each vendor’s own pages.

SpecKardia 12LMyoVista wavECG
Free tierNo / unverifiedNo / unverified
HIPAAYesYes
SOC 2 Type IIYesNo / unverified
EHR integrationsNot specifiedEpic
Foundedn/an/a
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.